Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
12/2002
12/27/2002WO2002102822A1 Adenosine derivative in polymorph ii form
12/27/2002WO2002102821A1 Adenosine derivative in polymorph i form
12/27/2002WO2002102800A1 5-(2-aminopyrimidin-4-yl) benzisoxazoles as protein kinase inhibitors
12/27/2002WO2002102787A2 Novel sulfonic acid derivatives
12/27/2002WO2002102778A1 Phenylpyridine carbonyl piperazine derivative
12/27/2002WO2002102771A1 Tryptase inhibitors
12/27/2002WO2002102403A1 Mucosal repair by tff dimer peptides
12/27/2002WO2002102399A2 Mucosal repair by tff2 peptides
12/27/2002WO2002102383A1 Aqueous cilostazol preparation for injection
12/27/2002WO2002102320A2 Fce fusion proteins for treatment of allergy and asthma
12/27/2002WO2002102315A2 QUINAZOLINE AND PYRIDO[2,3-d]PYRIMIDINE INHIBITORS OF PHOSPHODIESTERASE (PDE) 7
12/27/2002WO2002102314A2 Purine inhibitors of phosphodiesterase (pde) 7
12/27/2002WO2002102313A2 Pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002WO2002102310A2 Proteins associated with cell growth, differentiation, and death
12/27/2002WO2002076946A3 Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain.
12/27/2002WO2002057302A3 A virus causing respiratory tract illness in susceptible mammals
12/27/2002WO2002055099A3 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors
12/27/2002WO2002055087B1 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
12/27/2002WO2002045695A3 Hydrostatic delivery system for controlled delivery of agent
12/27/2002WO2002018445A8 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
12/27/2002WO2001074903A9 Cd20/ige-receptor like molecules and uses thereof
12/27/2002CA2455387A1 Fce fusion proteins for treatment of allergy and asthma
12/27/2002CA2455254A1 Moraxella (branhamella) catarrhalis antigens
12/27/2002CA2450936A1 Purine inhibitors of phosphodiesterase (pde) 7
12/27/2002CA2450934A1 Pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002CA2450724A1 Quinazoline and pyrido¬2,3-d|pyrimidine inhibitors of phosphodiesterase (pde) 7
12/27/2002CA2450659A1 Tryptase inhibitors
12/27/2002CA2450067A1 Proteins associated with cell growth, differentiation, and death
12/27/2002CA2448298A1 Phenylpyridine carbonyl piperazine derivative
12/27/2002CA2443466A1 An aqueous pharmaceutical preparation of cilostazol for parenteral use
12/26/2002US20020198412 (1R, 2S, 5R)-3-1-menthoxyalkan-1-OL cooling sensate
12/26/2002US20020198407 Antiallergy agents and bronchodilators
12/26/2002US20020198367 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof
12/26/2002US20020198255 2,4-substituted pyrrolidine derivatives-CCR-3 receptor antagonists
12/26/2002US20020198251 Substituted 2-dialkylaminoalkylbiphenyl derivatives
12/26/2002US20020198237 2,5-substituted imidazole compounds useful as histamine H3 receptor mediators
12/26/2002US20020198236 Small organic molecule regulators of cell proliferation
12/26/2002US20020198214 Such as (3-(4-(4-fluoro-benzyl)-piperidine-1-carbonyl)-4-methoxy-phenyl)-oxo-acetic acid methyl ester for proinflammation response in multiple sclerosis, inflammatory bowel disease, osteoarthritis, and other arthritic conditions
12/26/2002US20020198199 Such as 2-(2-(N-((4-aminoiminomethylphenyl)methyl)-3-(3-aminophenyl)-6-(N,N -dimethylhydrazino)-1-oxypyridinyl))acetami de which inhibit serine proteases for preventing and treating thrombotis
12/26/2002US20020198198 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
12/26/2002US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa
12/26/2002US20020198177 Coenzyme Q and EPA
12/26/2002US20020198143 B7-like polynucleotides, polypeptides, and antibodies
12/26/2002US20020197654 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
12/26/2002US20020197609 Method of determining a chemotherapeutic regimen based on glutathione-S-transferase pi expression
12/26/2002US20020197235 Method for short-term and long-term drug dosimetry
12/26/2002US20020197212 Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
12/25/2002CN1387531A Pyrazolo [4,3-d] pyrimidine derivs.
12/25/2002CN1387530A Imidazopyridine derivs. used as phosphodiesterase VII inhibitors
12/25/2002CN1387526A Cyclopropanes as CGRP antagonists, medicaments contg. said compounds and method for production thereof
12/25/2002CN1387508A N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
12/25/2002CN1387444A Method of treatment using anti-ErbB antibody-maytansinoid conjugates
12/25/2002CN1387441A Use of nitric oxide for treatment of airway constriction
12/25/2002CN1387433A Method for administering phosphodiesterase 4 inhibitor
12/25/2002CN1387431A Combination comprising beta 2 adranoreceptor agonist and lenkotriene receptor antagonist
12/25/2002CN1387404A Method and compositions for treating pulmonary diseases
12/25/2002CN1386544A Medicinally health-care powder made of ganoderma and lentinan
12/25/2002CN1386542A Chinese-medicinal oral liquid for treating rhinitis and nasosinusitis and its preparing process
12/25/2002CN1386516A Chinese-medicinal capsule for treating cough asthma
12/25/2002CN1097051C N-heteroaryl-pyridinesulfonamide derivs. and their use as endotheliin antagonists
12/24/2002US6498274 Amide derivatives for the treatment of diseases mediated by cytokines
12/24/2002US6498178 Inhibitors of IMPDH enzyme
12/24/2002US6498177 Alpha 2 adrenergic receptor agonist; analgesic, sedative and anaesthetic agents
12/24/2002US6498173 Treatment of diseases based on acute or chronic obstruction of vessels and/or bronchi and/or inflammation
12/24/2002US6498162 Treating inflammatory and allergic diseases of respiratory tract and diseases of central nervous system
12/24/2002US6498160 For therapy of emphysema, chronic bronchitis, asthma and allergic rhinitis
12/24/2002US6498158 Il-5 inhibiting 6-azauracil derivatives
12/24/2002US6498148 Immunization-free methods for treating antigen-stimulated inflammation in a mammalian host and shifting the host's antigen immune responsiveness to a Th1 phenotype
12/24/2002CA2150812C Catechol diethers as selective pde iv inhibitors
12/24/2002CA2075878C Cyclic peptides and use thereof
12/21/2002CA2390966A1 Compound for the treatment of atherosclerotic-thrombotic pathological conditions
12/19/2002WO2002101048A2 NEW POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-7 GENE
12/19/2002WO2002101009A2 Structural and cytoskeleton-associated proteins
12/19/2002WO2002100899A2 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
12/19/2002WO2002100890A2 Respiratory syncytial virus
12/19/2002WO2002100859A1 Pde iv inhibitors
12/19/2002WO2002100849A2 Novel nitriles useful as reversible inhibitors of cysteine proteases
12/19/2002WO2002100830A1 Pyrrolidine derivatives as factor xa inhibitors
12/19/2002WO2002100823A1 New compounds useful in reflux disease
12/19/2002WO2002100819A1 N-arylphenylacetamide derivatives and medicinal compositions containing the same
12/19/2002WO2002100409A1 Antiinflammatoric and antitussive compositions
12/19/2002WO2002100405A1 Isoquinoline inhibitors of p38
12/19/2002WO2002100336A2 Tissue-specific endothelial membrane proteins
12/19/2002WO2002100332A2 Isoxazoline compounds having mif antagonist activity
12/19/2002WO2002100330A2 METHODS OF ADMINISTERING ANTI-TNFα ANTIBODIES
12/19/2002WO2002100327A2 Substituted 1-benzazepines and derivatives thereof
12/19/2002WO2002100319A2 Method for cleaning hard gelatine capsules
12/19/2002WO2002085906A3 Phthalazinones derivatives useful as pde4/7 inhibitors
12/19/2002WO2002085308A3 Antisense and anti-inflammatory based compositions to treat respiratory disorders
12/19/2002WO2002080754A3 Methods for using annexin for detecting cell death in vivo and treating associated conditions
12/19/2002WO2002070565A3 High-affinity antagonists of elr-cxc chemokines
12/19/2002WO2002070561A3 Nuclear hormone receptor ligand binding domain
12/19/2002WO2002070560A3 Nuclear hormone receptor ligand binding domain
12/19/2002WO2002070558A3 Nuclear hormone receptor ligand binding domain
12/19/2002WO2002070515A3 Chromane derivatives, process for their preparation and their use as antitumor agents
12/19/2002WO2002060894A3 Sulfonamide lactam inhibitors of factor xa
12/19/2002WO2002058705A3 Degradation-resistant glucocorticosteroid formulations
12/19/2002WO2002055501A3 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them
12/19/2002WO2002028887A3 Use of lipopeptides or lipoproteins for treating lung infections and lung tumours
12/19/2002WO2001068859A9 Il-17 receptor like molecules and uses thereof
1 ... 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 ... 878